Bristol-Myers Squibb has rebounded strongly in 2024, driven by key drug approvals and positive financial performance. See why ...

All traffic has been stopped on the M5 after a crash near Bristol this evening (Monday, December 30). The collision took ...

We recently compiled a list of the Long-Term Stock Portfolio: Best Stocks for 10 Years. In this article, we are going to take ...

The financial accounts of Bristol City's parent company, Bristol City Holdings Limited, for the year ended June 2024 show a pre-tax loss of £3.3m. The figures are a major improvement, however, on the ...

Bristol logistics tech company Huboo has been saved from administration and bought by an investor consortium, the firm has ...

BRISTOL, Va. (WDBJ) - Fire crews were called back to the former Virginia Intermont College campus in Bristol this past ...

Freddie Potts and George Earthy faced off in the EFL Championship as Earthy’s Bristol City defeated Potts’ Portsmouth 3-0.

IL2-CD25 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Autoimmune Disorders.

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

Deucravacitinib is under clinical development by Bristol-Myers Squibb and currently in Phase II for Rosacea. According to GlobalData, Phase II drugs for Rosacea have a 38% phase transition success ...

BRISTOL, TENN. (WCYB) — The signs are up for a new restaurant in Bristol, Tennessee. Work is underway for a Cook Out ...